Charles York
Director of Finance/CFO bei DAY ONE BIOPHARMACEUTICALS, INC.
Vermögen: 5 Mio $ am 31.03.2024
Profil
Charles N.
York is currently the Chief Operating & Financial Officer at DOT Therapeutics-2, Inc. and the Chief Operating & Financial Officer, Secretary at Day One Biopharmaceuticals, Inc. Previously, he worked as the Controller at Astrotech Corp.
from 2009 to 2012 and as the Chief Financial Officer, Secretary & VP at Spyre Therapeutics, Inc. from 2014 to 2021.
Mr. York obtained his undergraduate degree from the University of Connecticut in 1999 and his MBA from the McCombs School of Business in 2006.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.03.2024 | 277 754 ( 0,32% ) | 5 Mio $ | 31.03.2024 |
Aktive Positionen von Charles York
| Unternehmen | Position | Beginn |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Director of Finance/CFO | 01.02.2021 |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Director of Finance/CFO | 17.02.2021 |
Ehemalige bekannte Positionen von Charles York
| Unternehmen | Position | Ende |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Director of Finance/CFO | 12.02.2021 |
| ASTROTECH CO. | Comptroller/Controller/Auditor | 01.08.2012 |
Ausbildung von Charles York
| University of Connecticut | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ASTROTECH CO. | Electronic Technology |
| SPYRE THERAPEUTICS, INC. | Health Technology |
| DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Health Technology |
